Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late Lactoferrin for Prevention of Neonatal Sepsis
NCT02959229Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, single-blind trial of bovine lactoferrin in neonatal sepsis (3 arms), sponsored by Ain Shams University. Primary endpoint: Effectiveness of oral Lactoferrin in prevention of neonatal sepsis. Started Aug 2014; status: completed.
02
Drugs
bovine lactoferrin
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NCT02959229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02959229.